Release Date: 17/05/22 08:23 Summary: Positive FDA Pre-IND meeting guides IHL-42X development Price Sensitive: Yes Download Document 145.8KB Download
PV1 Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response